Loading...
Loading...
Shares of Galena Biopharma
GALE are higher on the session by 13.32%, currently trading at $3.139. The stock has been moving largely higher over the past three weeks and is currently trading above the 50-day moving average.
Options traders are focusing on calls today. The strike seeing the heaviest volume is the April 2012 $1.00 call, which has traded 5,700 times on open interest of 1,008 contracts.
Calls are outpacing puts today by 6 to 1.
Galena Biopharma, Inc., formerly RXi Pharmaceuticals Corporation, is a biotechnology company focused on discovering, developing and commercializing therapies addressing unmet medical needs using RNAi-targeted and immunotherapy technologies.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in